Publications

Chen O, Jiang C, Berta T, Gray BP, Furutani K, Sullenger BA and Ji R-R. MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signalingPain. 2024; 165(8):1824-1839.

Requena M, Gray BP and Sullenger BA. Protocol for Purification of Cells in Their Native State Using Reversible Aptamer- Antidote PairsSTAR Protocols. 2023; 4:102348.

Song X, You H, Sullenger C, Gray BP, Yan A, Kelly L and Sullenger BA. An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor PathwayCancers. 2023; 15:2301.

Gray BP, Kelly L*, Steen-Burrell K-A*, Layzer JM, Rempel RE, Nimjee SM, Cooley BC, Tarantal AF and Sullenger BA. Rapid Molecular Imaging of Active Thrombi In Vivo Using Aptamer-Antidote ProbesMolecular Therapy Nucleic Acids. 2023; 31:440-451. * Co-second authors.

Puzo F, Zhang C, Gray BP, Zhang F, Sullenger BA and Kay MA. Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transferMolecular Therapy Nucleic Acids. 2023; 31:383-397.

Gray BP*, Song X*, Hsu DS, Kratschmer C, Levy M, Barry AP and Sullenger BA. An Aptamer for Broad Cancer Targeting and TherapyCancers. 2020; 12(11):3217. * Co-first authors. PMID – 33142831

Gray BP, Requena MA, Nichols M and Sullenger BA. Aptamers as Reversible Sorting Ligands for Preparation of Cells in their Native StateCell Chem Biol. 2020; 27:232-244. PMID – 31879266

Powell Gray B, Kelly L, Ahrens D, Barry A, Kratschmer C, Levy M and Sullenger BA. Tunable Cytotoxic Aptamer-Drug Conjugates for the Treatment of Prostate CancerPNAS. 2018; 115(18):4761-4766. PMID – 29666232

Gray BP and Brown KC. Combinatorial Peptide Libraries: Mining for Cell-Binding PeptidesChemical Reviews. 2014; 114(2):1020-1081. PMID – 24299061

McGuire MJ, Gray BP, Li S, Cupka D, Byers LA, Wu L, Rezaie S, Liu YH, Pattisapu N, Issac J, Oyama T, Diao L, Heymach JV, Xie XJ, Minna JD, Brown KC. Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer. Sci Rep. 2014; 4:4480. PMID – 24670678

Gray BP, McGuire MJ, and Brown KC. A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or DensityPLoS One. 2013; 8(8):e72938. PMID – 24009717

Gray BP, Li S, Brown KC. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker. Bioconjug Chem. 2013; 24(1):85-96. PMID – 23186007

Li S, Gray BP, McGuire MJ, Brown KC. Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integin αvβ. Bioorg Med Chem. 2011; 19(18):5480-5489. PMID – 21868241

Powell BD, Powell GL, Reeves PC. Phosphonium Ionic Liquids as Solvents for Nitration Reactions of ArenesLetters in Organic Chem. 2005; 2:550-553.